Latest On Summit Therapeutics Inc (SMMT):
About Summit Therapeutics Inc (SMMT):
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridium difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also develops DDS-01 series to treat infection caused by the bacteria Neisseria gonorrhoeae through Discuva platform; and DDS-04 series to treat Enterobacteriaceae. Summit Therapeutics Inc. was founded in 2003 and is based in Cambridge, Massachusetts.
General
- Name Summit Therapeutics Inc
- Symbol SMMT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 70
- Fiscal Year EndJanuary
- IPO Date2015-03-05
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.summitplc.com
Valuation
- Price/Sales (Trailing 12 Mt.) 496.65
- Price/Book (Most Recent Quarter) 6.4
- Enterprise Value Revenue 514.24
Financials
- Most Recent Quarter 2020-07-31
- Operating Margin -6085%
- Return on Assets -36%
- Return on Equity -90%
- Revenue 860000
- Earnings Per Share $1.23
- Revenue Per Share $0.01
- Gross Profit 860000
- Quarterly Earnings Growth 14.9%
Highlights
- Market Capitalization 483.06 million
- PE Ratio -4.39
- Analyst Target Price $4.5
- Book Value Per Share $0.55
Share Statistics
- Shares Outstanding 82.58 million
- Shares Float 21.64 million
- % Held by Insiders 7357%
- % Held by Institutions 10.54%
- Shares Short 367244
- Shares Short Prior Month 289991
- Short Ratio 1.16
- Short % of Float 1%
Technicals
- Beta 0.62
- 52 Week High $10.99
- 52 Week Low $1.94
- 50 Day Moving Average 7.13
- 200 Day Moving Average 4.98
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Summit Therapeutics Inc (SMMT) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Summit Therapeutics Inc (SMMT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2021-01-31 | 2021-01-31 | -$0.90 | $0.00 | ||
2020-10-31 | 2020-11-16 | -$1.24 | -$0.01 | -12300% | |
2020-07-31 | 2020-09-29 | $N/A | -$1.15 | -$0.02 | -5650% |
2020-04-30 | 2020-06-02 | $N/A | -$0.10 | ||
2019-10-31 | 2019-12-17 | $124000 | -$0.22 | -$0.40 | 45% |
2019-07-31 | 2019-10-11 | $126000 | -$0.20 | -$0.56 | 64.29% |
2019-04-30 | 2019-06-26 | $249000 | -$0.20 | -$0.16 | -25% |
2019-01-31 | 2019-03-27 | $505000 | -$0.35 | -$0.24 | -45.83% |
2018-10-31 | 2018-12-11 | $4.47 million | -$0.65 | -$0.31 | -109.68% |
2018-07-31 | 2018-09-20 | $52.65 million | $2.12 | -$0.37 | 672.97% |
2018-04-30 | 2018-06-05 | $10.09 million | -$0.52 | -$0.75 | 30.67% |
2018-01-31 | 2018-04-11 | $7.97 million | -$1.15 | -$0.66 | -74.24% |
2017-10-31 | 2017-12-06 | $3.35 million | -$0.20 | -$0.58 | 65.52% |
2017-07-31 | 2017-08-31 | $25.05 million | $1.10 | $0.35 | 214.29% |
2017-04-30 | 2017-06-14 | $2.24 million | -$0.48 | -$0.17 | -182.47% |
2017-01-31 | 2017-03-29 | $2.2 million | -$0.50 | -$0.48 | -4.17% |
2016-10-31 | 2016-12-15 | $695000 | -$0.45 | $3.01 | -114.95% |
2016-07-31 | 2016-09-08 | $10000 | -$0.65 | -$0.65 | 0% |
2016-04-30 | 2016-05-10 | $86000 | -$0.55 | -$0.86 | 36.05% |
2015-10-31 | 2015-12-17 | $490000 | -$0.59 | ||
2015-07-31 | 2015-08-27 | $519000 | -$0.52 | ||
2015-04-30 | 2015-05-06 | $625000 | -$0.11 |
Summit Therapeutics Inc (SMMT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Summit Therapeutics Inc (SMMT) Chart:
Summit Therapeutics Inc (SMMT) News:
Below you will find a list of latest news for Summit Therapeutics Inc (SMMT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Summit Therapeutics Inc (SMMT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-04-19 | 1 | 2.45 | CALL | 0 | 15 | 0 | TRUE | 0 | 0 |
2024-04-19 | 2 | 2.8 | CALL | 0 | 16 | 319.26 | TRUE | 0 | 0 |
2024-04-19 | 3 | 0.5 | CALL | 0 | 184 | 79.92 | TRUE | 0 | 0 |
2024-04-19 | 4 | 0.15 | CALL | 2 | 683 | 66.33 | FALSE | -0.15 | -0.5 |
2024-04-19 | 5 | 0.1 | CALL | 1 | 795 | 115.16 | FALSE | 0 | 0 |
2024-04-19 | 6 | 0.05 | CALL | 0 | 826 | 0 | FALSE | 0 | 0 |
2024-04-19 | 7 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 8 | 0.15 | CALL | 0 | 17 | 0 | FALSE | 0 | 0 |
2024-04-19 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2 | 0.05 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-04-19 | 3 | 0.17 | PUT | 0 | 45 | 0 | FALSE | 0 | 0 |
2024-04-19 | 4 | 0.5 | PUT | 5 | 82 | 97.4 | TRUE | 0.5 | 0 |
2024-04-19 | 5 | 1.38 | PUT | 0 | 123 | 170.21 | TRUE | 0 | 0 |
2024-04-19 | 6 | 0 | PUT | 0 | 0 | 500.73 | TRUE | 0 | 0 |
2024-04-19 | 7 | 2.4 | PUT | 0 | 2 | 527.35 | TRUE | 0 | 0 |
2024-04-19 | 8 | 0 | PUT | 0 | 0 | 560.47 | TRUE | 0 | 0 |
2024-05-17 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-05-17 | 2 | 0 | CALL | 0 | 0 | 314.57 | TRUE | 0 | 0 |
2024-05-17 | 3 | 0 | CALL | 0 | 31 | 66.72 | TRUE | 0 | 0 |
2024-05-17 | 4 | 0.3 | CALL | 2 | 122 | 70.47 | FALSE | -0.15 | -0.33 |
2024-05-17 | 5 | 0.39 | CALL | 1 | 520 | 136.69 | FALSE | 0.14 | 0.56 |
2024-05-17 | 6 | 0.15 | CALL | 0 | 101 | 0 | FALSE | 0 | 0 |
2024-05-17 | 7 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 8 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 4 | 0 | PUT | 0 | 0 | 360.02 | TRUE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 324.15 | TRUE | 0 | 0 |
2024-05-17 | 6 | 0 | PUT | 0 | 0 | 202.92 | TRUE | 0 | 0 |
2024-05-17 | 7 | 0 | PUT | 0 | 0 | 344.31 | TRUE | 0 | 0 |
2024-05-17 | 8 | 0 | PUT | 0 | 0 | 321.53 | TRUE | 0 | 0 |
2024-07-19 | 1 | 1.75 | CALL | 0 | 0 | 148.7 | TRUE | 0 | 0 |
2024-07-19 | 2 | 2.81 | CALL | 0 | 2 | 235.97 | TRUE | 0 | 0 |
2024-07-19 | 3 | 1.15 | CALL | 0 | 98 | 297.49 | TRUE | 0 | 0 |
2024-07-19 | 4 | 0.66 | CALL | 1 | 96 | 88.62 | FALSE | -0.14 | -0.18 |
2024-07-19 | 5 | 0.35 | CALL | 0 | 157 | 106.34 | FALSE | 0 | 0 |
2024-07-19 | 6 | 0.33 | CALL | 0 | 97 | 106.84 | FALSE | 0 | 0 |
2024-07-19 | 7 | 0.4 | CALL | 0 | 25 | 109.19 | FALSE | 0 | 0 |
2024-07-19 | 8 | 0.3 | CALL | 0 | 171 | 114.07 | FALSE | 0 | 0 |
2024-07-19 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 3 | 0.5 | PUT | 0 | 76 | 95.87 | FALSE | 0 | 0 |
2024-07-19 | 4 | 0.6 | PUT | 0 | 126 | 122.37 | TRUE | 0 | 0 |
2024-07-19 | 5 | 1.05 | PUT | 0 | 10 | 169.2 | TRUE | 0 | 0 |
2024-07-19 | 6 | 0 | PUT | 0 | 0 | 148.33 | TRUE | 0 | 0 |
2024-07-19 | 7 | 0 | PUT | 0 | 0 | 221.84 | TRUE | 0 | 0 |
2024-07-19 | 8 | 0 | PUT | 0 | 0 | 182.82 | TRUE | 0 | 0 |
2024-10-18 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-10-18 | 2 | 0 | CALL | 0 | 0 | 269.08 | TRUE | 0 | 0 |
2024-10-18 | 3 | 0 | CALL | 0 | 0 | 223.67 | TRUE | 0 | 0 |
2024-10-18 | 4 | 0.95 | CALL | 0 | 119 | 251.44 | FALSE | 0 | 0 |
2024-10-18 | 5 | 1.3 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
2024-10-18 | 6 | 1 | CALL | 0 | 81 | 0 | FALSE | 0 | 0 |
2024-10-18 | 7 | 0.3 | CALL | 0 | 102 | 91.06 | FALSE | 0 | 0 |
2024-10-18 | 8 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 9 | 0.55 | CALL | 0 | 0 | 104.24 | FALSE | 0 | 0 |
2024-10-18 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 2 | 0.25 | PUT | 0 | 1 | 170.12 | FALSE | 0 | 0 |
2024-10-18 | 3 | 0 | PUT | 0 | 0 | 216.62 | FALSE | 0 | 0 |
2024-10-18 | 4 | 1.3 | PUT | 0 | 4 | 162.45 | TRUE | 0 | 0 |
2024-10-18 | 5 | 2.55 | PUT | 0 | 1 | 164.47 | TRUE | 0 | 0 |
2024-10-18 | 6 | 0 | PUT | 0 | 0 | 164.2 | TRUE | 0 | 0 |
2024-10-18 | 7 | 0 | PUT | 0 | 0 | 183.6 | TRUE | 0 | 0 |
2024-10-18 | 8 | 0 | PUT | 0 | 0 | 168.61 | TRUE | 0 | 0 |
2024-10-18 | 9 | 0 | PUT | 0 | 0 | 192.69 | TRUE | 0 | 0 |
2025-01-17 | 1 | 2.5 | CALL | 0 | 773 | 93.47 | TRUE | 0 | 0 |
2025-01-17 | 2 | 2.43 | CALL | 0 | 596 | 90.83 | TRUE | 0 | 0 |
2025-01-17 | 3 | 1.7 | CALL | 0 | 213 | 96.7 | TRUE | 0 | 0 |
2025-01-17 | 4 | 1.1 | CALL | 0 | 270 | 112.38 | FALSE | 0 | 0 |
2025-01-17 | 5 | 1.09 | CALL | 0 | 1027 | 116.26 | FALSE | 0 | 0 |
2025-01-17 | 7 | 0.65 | CALL | 0 | 49 | 85.14 | FALSE | 0 | 0 |
2025-01-17 | 10 | 0.4 | CALL | 4 | 1010 | 101.11 | FALSE | 0 | 0 |
2025-01-17 | 1 | 0.1 | PUT | 0 | 540 | 0 | FALSE | 0 | 0 |
2025-01-17 | 2 | 0.3 | PUT | 0 | 4 | 196.56 | FALSE | 0 | 0 |
2025-01-17 | 3 | 1.2 | PUT | 0 | 1 | 171.11 | FALSE | 0 | 0 |
2025-01-17 | 4 | 2.1 | PUT | 0 | 10 | 170.08 | TRUE | 0 | 0 |
2025-01-17 | 5 | 2.8 | PUT | 0 | 69 | 102.6 | TRUE | 0 | 0 |
2025-01-17 | 7 | 5.3 | PUT | 0 | 35 | 111.05 | TRUE | 0 | 0 |
2025-01-17 | 10 | 8 | PUT | 0 | 2 | 122.58 | TRUE | 0 | 0 |
Latest SMMT Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:55 PM EST | 334 | $0.9325 |
Jun 13, 2022 7:55 PM EST | 100 | $0.9301 |
Jun 13, 2022 7:56 PM EST | 100 | $0.9301 |
Jun 13, 2022 7:57 PM EST | 100 | $0.9338 |
Jun 13, 2022 7:58 PM EST | 282 | $0.9354 |
Summit Therapeutics Inc (SMMT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000024/0001599298-20-000024-index.htm |
2019-06-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1599298/000000000019009889/0000000000-19-009889-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1599298/000089914019000232/0000899140-19-000232-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025702/0000899243-20-025702-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025705/0000899243-20-025705-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025706/0000899243-20-025706-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025707/0000899243-20-025707-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025711/0000899243-20-025711-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025712/0000899243-20-025712-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025713/0000899243-20-025713-index.htm |
2020-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000089924320025714/0000899243-20-025714-index.htm |
2019-01-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000091957419000328/0000919574-19-000328-index.htm |
2020-03-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000091957420002580/0000919574-20-002580-index.htm |
2020-05-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000091957420003557/0000919574-20-003557-index.htm |
2020-06-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000091957420004158/0000919574-20-004158-index.htm |
2019-01-22 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189519000132/0000921895-19-000132-index.htm |
2019-12-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189519002958/0000921895-19-002958-index.htm |
2019-12-27 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189519003085/0000921895-19-003085-index.htm |
2020-01-16 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189520000126/0000921895-20-000126-index.htm |
2020-01-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189520000159/0000921895-20-000159-index.htm |
2020-09-28 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189520002482/0000921895-20-002482-index.htm |
2020-09-28 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189520002483/0000921895-20-002483-index.htm |
2020-10-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1599298/000092189520002546/0000921895-20-002546-index.htm |
2020-10-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000092189520002547/0000921895-20-002547-index.htm |
2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000092189520002557/0000921895-20-002557-index.htm |
2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1599298/000092189520002819/0000921895-20-002819-index.htm |
2019-01-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519002553/0001193125-19-002553-index.htm |
2019-01-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519005734/0001193125-19-005734-index.htm |
2019-01-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519008984/0001193125-19-008984-index.htm |
2019-02-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519037930/0001193125-19-037930-index.htm |
2019-04-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519094502/0001193125-19-094502-index.htm |
2019-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519146672/0001193125-19-146672-index.htm |
2019-06-12 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1599298/000119312519170783/0001193125-19-170783-index.htm |
2019-06-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1599298/000119312519175621/0001193125-19-175621-index.htm |
2019-06-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519175657/0001193125-19-175657-index.htm |
2019-06-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519176472/0001193125-19-176472-index.htm |
2019-06-21 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519178809/0001193125-19-178809-index.htm |
2019-12-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519307884/0001193125-19-307884-index.htm |
2019-12-06 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519308304/0001193125-19-308304-index.htm |
2019-12-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519322604/0001193125-19-322604-index.htm |
2019-12-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312519323133/0001193125-19-323133-index.htm |
2020-01-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520013203/0001193125-20-013203-index.htm |
2020-01-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520015354/0001193125-20-015354-index.htm |
2020-02-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520026771/0001193125-20-026771-index.htm |
2020-02-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520050061/0001193125-20-050061-index.htm |
2020-04-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520107186/0001193125-20-107186-index.htm |
2020-04-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520112150/0001193125-20-112150-index.htm |
2020-04-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520127953/0001193125-20-127953-index.htm |
2020-05-21 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1599298/000119312520148813/0001193125-20-148813-index.htm |
2020-07-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520199664/0001193125-20-199664-index.htm |
2020-09-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000119312520247611/0001193125-20-247611-index.htm |
2020-09-18 | 8-K12B | Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b) | https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/0001193125-20-248702-index.htm |
2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1599298/000119312520257178/0001193125-20-257178-index.htm |
2020-10-05 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1599298/000119312520263921/0001193125-20-263921-index.htm |
2020-10-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1599298/000119312520263928/0001193125-20-263928-index.htm |
2020-10-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1599298/000119312520263935/0001193125-20-263935-index.htm |
2020-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1599298/000119380520001233/0001193805-20-001233-index.htm |
2020-10-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1599298/000119380520001258/0001193805-20-001258-index.htm |
2020-09-18 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1599298/000135445720000486/0001354457-20-000486-index.htm |
2019-01-18 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1599298/000159929819000002/0001599298-19-000002-index.htm |
2019-03-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929819000005/0001599298-19-000005-index.htm |
2019-03-29 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1599298/000159929819000008/0001599298-19-000008-index.htm |
2019-06-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929819000011/0001599298-19-000011-index.htm |
2019-10-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929819000017/0001599298-19-000017-index.htm |
2019-10-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929819000018/0001599298-19-000018-index.htm |
2019-12-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929819000024/0001599298-19-000024-index.htm |
2020-01-02 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000001/0001599298-20-000001-index.htm |
2020-04-30 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000005/0001599298-20-000005-index.htm |
2020-05-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000008/0001599298-20-000008-index.htm |
2020-06-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000012/0001599298-20-000012-index.htm |
2020-06-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000014/0001599298-20-000014-index.htm |
2020-06-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000016/0001599298-20-000016-index.htm |
2020-06-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000018/0001599298-20-000018-index.htm |
2020-06-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000021/0001599298-20-000021-index.htm |
2020-07-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000024/0001599298-20-000024-index.htm |
2020-07-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000026/0001599298-20-000026-index.htm |
2020-07-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000028/0001599298-20-000028-index.htm |
2020-07-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000031/0001599298-20-000031-index.htm |
2020-08-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000033/0001599298-20-000033-index.htm |
2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1599298/000159929820000039/0001599298-20-000039-index.htm |
2019-06-20 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1599298/999999999519001397/9999999995-19-001397-index.htm |
2020-10-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1599298/999999999520002867/9999999995-20-002867-index.htm |
2019-04-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1599298/999999999719003399/9999999997-19-003399-index.htm |